Sumaroka, A.; Cideciyan, A.V.; Charng, J.; Wu, V.; Powers, C.A.; Iyer, B.S.; Lisi, B.; Swider, M.; Jacobson, S.G.
Autosomal Dominant Retinitis Pigmentosa Due to Class B Rhodopsin Mutations: An Objective Outcome for Future Treatment Trials. Int. J. Mol. Sci. 2019, 20, 5344.
https://doi.org/10.3390/ijms20215344
AMA Style
Sumaroka A, Cideciyan AV, Charng J, Wu V, Powers CA, Iyer BS, Lisi B, Swider M, Jacobson SG.
Autosomal Dominant Retinitis Pigmentosa Due to Class B Rhodopsin Mutations: An Objective Outcome for Future Treatment Trials. International Journal of Molecular Sciences. 2019; 20(21):5344.
https://doi.org/10.3390/ijms20215344
Chicago/Turabian Style
Sumaroka, Alexander, Artur V. Cideciyan, Jason Charng, Vivian Wu, Christian A. Powers, Bhavya S. Iyer, Brianna Lisi, Malgorzata Swider, and Samuel G. Jacobson.
2019. "Autosomal Dominant Retinitis Pigmentosa Due to Class B Rhodopsin Mutations: An Objective Outcome for Future Treatment Trials" International Journal of Molecular Sciences 20, no. 21: 5344.
https://doi.org/10.3390/ijms20215344
APA Style
Sumaroka, A., Cideciyan, A. V., Charng, J., Wu, V., Powers, C. A., Iyer, B. S., Lisi, B., Swider, M., & Jacobson, S. G.
(2019). Autosomal Dominant Retinitis Pigmentosa Due to Class B Rhodopsin Mutations: An Objective Outcome for Future Treatment Trials. International Journal of Molecular Sciences, 20(21), 5344.
https://doi.org/10.3390/ijms20215344